Clinical Trial Update: Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating the combination of butylphthalide and tenecteplase for improving neurological function in patients with mild disabling ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disabling Acute Ischemic Stroke

Drugs mentioned

• Butylphthalide (butylphthalide)
• Tenecteplase (tenecteplase)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Mild Disabling Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING